Get started
Author

Siting Gao

Observed names: Gao, Siting, Si-Ting Gao, Si-ting Gao
ORCID: 0009-0003-9523-0844
Observed ORCID: 0009-0003-9523-0844
OpenAlex ID: A5071595650
The Beneficial Effects of Geniposide on Glucose and Lipid Metabolism: A Review
2022 · Siting Gao, Qin Feng · Drug Design Development and Therapy · 39
PDF
USP5: Comprehensive insights into structure, function, biological and disease-related implications, and emerging therapeutic opportunities
2023 · Si-Ting Gao, Xin Xin, et al. · Molecular and Cellular Probes · 35
Exploring the protective effect of Modified Xiaochaihu Decoction against hepatic steatosis and inflammation by network pharmacology and validation in ageing rats
2020 · Siting Gao, Tongzhuang Wang, et al. · Chinese Medicine · 11
PDF
Effectiveness and safety analysis of Danggui Shaoyao Powder for the treatment of non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled clinical trial
2023 · Qian Huang, Ziming An, et al. · BMC Complementary Medicine and Therapies · 7
PDF
IL-1 receptor-associated kinase family proteins: An overview of their role in liver disease
2024 · Zhuo-yuan Wang, Si-ting Gao, et al. · European Journal of Pharmacology · 5
The Application Research of Description Logic in Civil Aviation Domain Ontology
2011 · Hong Wang, Siting Gao, et al. · International Conference on Management and Service Science (MASS) · 4
Danggui-Shaoyao-San protects against non-alcoholic steatohepatitis via modulation of hepatic APP protein, Lysosomal CTSB release, and NF-κB activation
2024 · Siting Gao, Ziming An, et al. · Heliyon · 1
The Description Logic Based on Static Extension Set
2012 · Jing Wang, Dong Jian-kang, et al. · IC3T '12 Proceedings of the 2012 International Conference on Convergence Computer Technology · 1
Activation of hepatic USP5 as a novel strategy to ameliorate metabolic dysfunction-associated steatotic liver disease by deubiquitinating CPT-1A
2026 · Feng Qin, Qinmei Sun, et al. · Research Square
PDF
Danggui-Shaoyao-San ameliorates metabolic dysfunction-associated steatohepatitis via suppressing hepatic macrophage NLRP3 inflammasome
2026 · Qian Huang, Sheng Lyu, et al. · Journal of Ethnopharmacology
Additional file 4 of Exploring the protective effect of Modified Xiaochaihu Decoction against hepatic steatosis and inflammation by network pharmacology and validation in ageing rats
2020 · Gao, Siting, Wang, Tongzhuang, et al. · Figshare
Additional file 6 of Exploring the protective effect of Modified Xiaochaihu Decoction against hepatic steatosis and inflammation by network pharmacology and validation in ageing rats
2020 · Gao, Siting, Wang, Tongzhuang, et al. · Figshare
Additional file 2 of Exploring the protective effect of Modified Xiaochaihu Decoction against hepatic steatosis and inflammation by network pharmacology and validation in ageing rats
2020 · Gao, Siting, Wang, Tongzhuang, et al. · Figshare
Additional file 1 of Exploring the protective effect of Modified Xiaochaihu Decoction against hepatic steatosis and inflammation by network pharmacology and validation in ageing rats
2020 · Gao, Siting, Wang, Tongzhuang, et al. · Figshare
Additional file 3 of Exploring the protective effect of Modified Xiaochaihu Decoction against hepatic steatosis and inflammation by network pharmacology and validation in ageing rats
2020 · Gao, Siting, Wang, Tongzhuang, et al. · Figshare
Additional file 5 of Exploring the protective effect of Modified Xiaochaihu Decoction against hepatic steatosis and inflammation by network pharmacology and validation in ageing rats
2020 · Gao, Siting, Wang, Tongzhuang, et al. · Figshare
An Approach to Acquisitions of Ontology Fuzzy Relations
2012 · Hong Wang, Zhiwei Xiao, et al. · IC3T '12 Proceedings of the 2012 International Conference on Convergence Computer Technology
Works count: 17
Citation count: 103
H-index: 5
I10-index: 3
Year
Topic
Type